Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Tissue Collection Study to Explore the Correlation Between ATM Genetic Alterations by Next-Generation Sequencing and ATM Loss-of-Protein Via IHC (ATR-ID Study)

NCT04976803 is registered in ClinicalTrials.gov with Artios Pharma Ltd as lead sponsor.

NCT NCT04976803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Tissue Collection Study to Explore the Correlation Between ATM Genetic Alterations by Next-Generation Sequencing and ATM Loss-of-Protein Via IHC (ATR-ID Study)
Lead sponsor
Artios Pharma Ltd
Phase
Observational
Overall status
Completed
Start date
May 28, 2021
Completion date
June 30, 2022
Enrollment
229 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, unspecified, adult